MPA Versus Dydrogesterone for Management of Endometrial Hyperplasia Without Atypia
NCT03675139
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
471
Enrollment
OTHER
Sponsor class
Conditions
Endometrial Hyperplasia Without Atypia
Interventions
DRUG:
Medroxyprogesterone Acetate
DRUG:
Dydrogesterone 10 MG
Sponsor
Xiaojun Chen